Recently, groundbreaking research on the NORTION® High-Frequency Irreversible Electroporation (H-FIRE) ablation system—developed independently by NORTION as a global leader in the field—was published in the Urology journal. The study not only validates the exceptional efficacy and safety of H-FIRE technology in treating Benign Prostatic Hyperplasia (BPH), but also provides robust scientific evidence for its clinical adoption."

Shanghai Nortion Medical Achieves Significant Breakthrough in Indonesia: Composite Steep Pulse Therapy Device and Disposable Ablation Electrode Needles Secure Import Medical Device Distribution License.

Following last month's achievement of the FDA Breakthrough Device Designation (BDD) for its independently developed Composite Steep Pulse Therapy Device, NORTION has now achieved major innovative breakthroughs on October 24!

NORTION's receipt of the FDA Breakthrough Device Designation (BDD) for its Composite Steep Pulse Therapy Device demonstrates the technology's cutting-edge innovation and exceptional clinical value. This achievement grants access to the U.S. innovation market...